ロード中...
Tocilizumab and COVID-19
The number of cases in COVID-19 pandemic is rising rapidly. There has not been a single effective proven medication for COVID-19 disease. Highest mortality has been reported among subjects who develop acute respiratory disease (ARDS). The histopathological analysis of lung specimens has given rise t...
保存先:
| 出版年: | Indian J Crit Care Med |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Jaypee Brothers Medical Publishers
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7584849/ https://ncbi.nlm.nih.gov/pubmed/33132549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5005/jp-journals-10071-23608 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|